Elisavet Prodromou takes over Sobi in Greece, Cyprus and Malta
Published
The company Sobi is opening a new chapter in Greece, Cyprus and Malta. From 16 November 2026, Elisavet Prodromou will take charge of the company's operations in all three countries.
Sobi is an international pharmaceutical company that works mainly in the field of rare diseases and specialised treatments. The company operates in many countries in Europe, and Greece, Cyprus and Malta are part of its region, which is managed by a shared team.
This change means that one single leadership will be responsible for all three markets. The report does not give more details about the new director's plans or about the changes that will be made to how the company operates.
She will start her duties in November 2026. Anyone interested in the company can follow its next announcements, which will give more information about its new direction.
Sources: Newsbeast
More Greece news
- Ask Maps is coming to Greece: A new way to search for places on Google Maps
- Google Maps and artificial intelligence: what changes for people travelling in Greece
- Motorola cuts its prices for Black Friday
- Pierrakakis: Greece can play a leading role in Artificial Intelligence through the digitalisation of the state
- Fifty-three years since the Polytechnic uprising: The messages for today
- From the Polytechnic to 2030: Mitsotakis's message on unity and stability
- PAME sends greetings to the 43rd AITUC Congress and to the workers of India
- Merck expands its clinical operations in Athens